Dissecting the Role of Nucleus Basalis Magnocellularis Circuitry in Basolateral Amygdala Physiology and Regulation of Anxiety Following Chronic Ethanol Exposure and Withdrawal
剖析大细胞基底核回路在基底外侧杏仁核生理学中的作用以及慢性乙醇暴露和戒断后焦虑的调节
基本信息
- 批准号:10454798
- 负责人:
- 金额:$ 2.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-01 至 2022-06-17
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAddressAffectAffectiveAlcohol abuseAlcohol dependenceAlcohol withdrawal syndromeAlcoholsAmygdaloid structureAnatomyAnti-Anxiety AgentsAnxietyAttenuatedBehaviorBehavioralBiological AssayBrain regionCell NucleusCellsCharacteristicsChronicClinicalCognitiveDataDepressed moodElectrophysiology (science)EmotionalEquilibriumEthanolExcitotoxic lesionExhibitsFellowshipFrightFunctional Magnetic Resonance ImagingGenerationsGlutamatesGoalsHeavy DrinkingHumanInterneuronsLaboratoriesLateralLeadLearningLesionLiteratureMeasuresMediatingMemoryMethodsModelingMolecularMuscarinic Acetylcholine ReceptorNational Research Service AwardsNeuronsNucleus Basalis MagnocellularisOutcomePatientsPersonsPhysiologyPopulationProcessPsychological reinforcementPublishingRegulationRelapseResearchRewardsRodentRoleSensorySymptomsSynapsesSynaptic plasticitySystemTechnical ExpertiseTechnologyTestingTherapeuticUnited StatesUp-RegulationWithdrawalWithdrawal Symptomalcohol exposurealcohol use disorderanxiety-like behaviorattenuationcareercholinergicconditioned feardepressive symptomseffective therapyemotional behaviorexperienceexperimental studyfield studygamma-Aminobutyric Acidhippocampal pyramidal neuroninnovationneuroadaptationneuronal excitabilityneurophysiologyneuroregulationneurotransmissionneurotransmitter releasenoveloptogeneticspatch clamppre-clinicalpresynapticpsychologicstria terminalistransmission processvaporwithdrawal-induced anxiety
项目摘要
PROJECT SUMMARY
Anxiety during alcohol withdrawal contributes to high relapse rates and remains an obstacle for alcohol use
disorder (AUD) treatment. The basolateral amygdala (BLA) is a brain region involved in the progression of
alcohol dependence that facilitates reward-seeking and emotional behaviors like anxiety. Our laboratory has
shown that input-specific alterations in glutamate/GABA neurotransmission occur following chronic
ethanol/withdrawal. For example, stria terminalis (ST) glutamatergic afferents exhibit presynaptic facilitation
during withdrawal. Lateral paracupsular cells (LPCs) and local interneurons of the BLA GABAergic system
express different outcomes to chronic ethanol: LPCs show an attenuation of GABA release, while local
interneurons show no significant change. Together, these alterations in GABAergic/glutamatergic afferents
yield a hyperexcitable state in BLA pyramidal neurons during alcohol withdrawal. However, it remains unclear
how ethanol alters the neurophysiology of upstream modulatory systems, or whether these projections
influence the generation of anxiety-like behaviors. The BLA receives dense cholinergic projections from the
nucleus basalis magnocellularis (NBM) to modulate neuronal excitability and neurotransmitt er release by
acting on GABAergic interneurons, glutamatergic terminals, and BLA pyramidal neurons. These distinct
neuronal compartments contain different combinations of nicotinic and muscarinic acetylcholine receptors
(n/mAChRs) that collectively function to regulate the formation of aversive memories. The effects of chronic
ethanol on NBM synaptic physiology and their roles in mediating withdrawal-induced anxiety-like behavior in
the BLA is unknown. Our preliminary data leads to the central hypothesis that chronic ethanol dysregulates
cholinergic modulation of BLA afferents and potentiates the neurophysiological symptoms of withdrawal. We
will address this hypothesis through two Specific Aims. In Aim 1, we will primarily employ optogenetic and
excitotoxic lesion studies to manipulate the activity of NBM terminals and measure GABA/glutamate
neurophysiology with whole-cell patch clamp electrophysiology. We hypothesize that chronic
ethanol/withdrawal upregulates NBM cholinergic input and enhances glutamatergic and GABAergic
presynaptic plasticity. In Aim 2, we will use chemogenetics and lesion experiments to manipulate the
cholinergic inputs and measure anxiety-like behavior using assays like the elevated zero maze, light/dark box,
and open field test. We hypothesize that disruption of the cholinergic circuit will ameliorate the progression of
anxiety-like behaviors. Understanding the NBM-BLA circuit might lead to potential novel targets for more
effective treatments of alcohol withdrawal-induced anxiety in the clinical setting.
项目摘要
戒酒期间的焦虑会导致高复发率,并且仍然是饮酒的障碍
障碍(AUD)治疗。基底外侧杏仁核(BLA)是参与参与的大脑区域
酒精依赖有助于寻求奖励和情感行为,例如焦虑。我们的实验室有
表明在慢性后发生谷氨酸/GABA神经传递的特异性变化
乙醇/退出。例如,Stria terminalis(ST)谷氨酸能传入表现出突触前的促进作用
在退出期间。 Bla Gabaergic系统的外侧副偏细胞(LPC)和局部神经元
对慢性乙醇表达不同的结果:LPC显示出GABA释放的衰减,而本地
中间神经元没有显着变化。加在一起的GABA能/谷氨酸能传入中的这些变化
在戒酒期间,在BLA锥体神经元中产生过度可见的状态。但是,还不清楚
乙醇如何改变上游调节系统的神经生理学,或者这些预测是否是
影响类似焦虑的行为的产生。 BLA从
底核核细胞(NBM)调节神经元兴奋性和神经释放性通过
作用于GABA能中间神经元,谷氨酸能末端和BLA锥体神经元。这些与众不同
神经元室包含烟碱和毒蕈碱乙酰胆碱受体的不同组合
(N/MACHR)共同起作用以调节厌恶记忆的形成。慢性的影响
NBM突触生理学的乙醇及其在介导戒断引起的焦虑行为中的作用
BLA是未知的。我们的初步数据导致了一个中心假设,即慢性乙醇失调
BLA传入的胆碱能调节并增强戒断的神经生理症状。我们
将通过两个具体目标解决这一假设。在AIM 1中,我们将主要采用光遗传学和
兴奋性病变研究以操纵NBM末端的活性并测量GABA/谷氨酸
神经生理学,全细胞贴片夹电生理学。我们假设那个慢性
乙醇/戒断会上调NBM胆碱能输入并增强谷氨酸能和GABA能
突触前可塑性。在AIM 2中,我们将使用化学遗传学和病变实验来操纵
胆碱能输入和使用高架迷宫,浅色/深色盒子等测定法测量焦虑般的行为
和开放式测试。我们假设胆碱能回路的破坏将改善
焦虑般的行为。了解NBM-BLA电路可能会导致潜在的新目标
在临床环境中,有效治疗酒精戒断引起的焦虑。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah Elizabeth Sizer其他文献
Sarah Elizabeth Sizer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
- 批准号:
10701309 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Circuit control of motivation to take and seek alcohol
饮酒和寻求酒精动机的电路控制
- 批准号:
10753712 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
- 批准号:
10736443 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Sex-specific Impact of Prenatal Opioids on Brain Reward Signaling and Neonatal Feeding Regulation
产前阿片类药物对大脑奖赏信号和新生儿喂养调节的性别特异性影响
- 批准号:
10506345 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别:
Integrated Treatment for Enhancing Growth in Recovery during Adolescence (InTEGRA)
促进青春期恢复生长的综合治疗 (InTEGRA)
- 批准号:
10680616 - 财政年份:2023
- 资助金额:
$ 2.59万 - 项目类别: